LabCorp Buys Monogram Biosciences To Bolster Companion Dx Portfolio
This article was originally published in The Gray Sheet
Executive Summary
LabCorp will expand its foothold in personalized medicine through its $155 million acquisition of companion diagnostics developer Monogram Biosciences